Conference: 2014 International PHA Conference and Scientific Sessions
Release Date: 03.27.2017
Nancy Blair, RN, CNS-BC Cleveland Clinic, Health System Cleveland, Ohio
To support the attainment of knowledge, competence, and performance, the learner should be able to achieve the following objectives:
Complete the referral process for PAH therapies
Utilize the intranet for obtaining therapies
Understand patient assistance options
Understand the appeal process when medications are denied
This educational activity is intended for;
Unapproved/Off-Label Use Disclosure
When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved)
Any limitations on the information presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty may discuss information about pharmaceutical agents that is outside of FDA-approved labeling. This information is intended solely for CME and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
Faculty, Planners, Staff Disclosure Information
All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity. The faculty and planners of this educational activity disclose the following:
Nancy Blair, RN, MSN, CNS-BC, indicates no significant relationships to disclose.
PHA and PESG Staff have no relevant financial relationships to disclose.